Variant report

Variant	esv2470969
Chromosome Location	chr2:64077035-64078477
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:64077326-64077490	K562	blood:	n/a	n/a
2	ATF2	chr2:64076244-64077370	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr2:64075774-64077625	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr2:64077994-64078712	H1-hESC	embryonic stem cell:	n/a	n/a
5	EP300	chr2:64076587-64077088	H1-hESC	embryonic stem cell:	n/a	n/a
6	FOS	chr2:64077390-64077631	MCF10A-Er-Src	breast:	n/a	chr2:64077487-64077497 chr2:64077488-64077496 chr2:64077489-64077496 chr2:64077488-64077496
7	FOS	chr2:64077328-64077618	MCF10A-Er-Src	breast:	n/a	chr2:64077487-64077497 chr2:64077488-64077496 chr2:64077489-64077496 chr2:64077488-64077496
8	FOS	chr2:64077359-64077534	MCF10A-Er-Src	breast:	n/a	chr2:64077487-64077497 chr2:64077488-64077496 chr2:64077489-64077496 chr2:64077488-64077496
9	GTF2F1	chr2:64076614-64077131	H1-hESC	embryonic stem cell:	n/a	n/a
10	IRF1	chr2:64077712-64078122	K562	blood:	n/a	chr2:64077938-64077951 chr2:64077937-64077951 chr2:64077937-64077948 chr2:64077938-64077951 chr2:64077935-64077949 chr2:64077933-64077950 chr2:64077938-64077949 chr2:64077938-64077950
11	MAFF	chr2:64077322-64077664	HepG2	liver:	n/a	chr2:64077479-64077497
12	MAFF	chr2:64077337-64077646	K562	blood:	n/a	chr2:64077479-64077497
13	MAFF	chr2:64076895-64077120	HepG2	liver:	n/a	n/a
14	MAFK	chr2:64077335-64077631	K562	blood:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
15	MAFK	chr2:64076889-64077108	HepG2	liver:	n/a	n/a
16	MAFK	chr2:64076927-64077633	HepG2	liver:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
17	MAFK	chr2:64077311-64077674	HepG2	liver:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
18	MAFK	chr2:64077325-64077641	Hela-S3	cervix:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
19	MAFK	chr2:64076612-64077660	H1-hESC	embryonic stem cell:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
20	MAFK	chr2:64076863-64077668	IMR90	lung:	n/a	chr2:64077484-64077500 chr2:64077481-64077496 chr2:64077482-64077502 chr2:64077486-64077496
21	MAX	chr2:64076774-64077055	H1-hESC	embryonic stem cell:	n/a	n/a
22	MAZ	chr2:64077513-64077529	HepG2	liver:	n/a	n/a
23	NANOG	chr2:64077057-64077306	H1-hESC	embryonic stem cell:	n/a	n/a
24	POLR2A	chr2:64076637-64077141	H1-hESC	embryonic stem cell:	n/a	n/a
25	POLR2A	chr2:64077635-64080768	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr2:64077854-64078008	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr2:64076558-64077230	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr2:64077742-64077991	H1-hESC	embryonic stem cell:	n/a	n/a
29	POLR2A	chr2:64066467-64077414	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr2:64076667-64077150	H1-hESC	embryonic stem cell:	n/a	n/a
31	RAD21	chr2:64076640-64077069	H1-hESC	embryonic stem cell:	n/a	n/a
32	RCOR1	chr2:64077857-64077858	HepG2	liver:	n/a	n/a
33	RFX5	chr2:64077020-64077040	HepG2	liver:	n/a	n/a
34	SP1	chr2:64076321-64077096	H1-hESC	embryonic stem cell:	n/a	n/a
35	STAT3	chr2:64077897-64077919	GM12878	blood:	n/a	n/a
36	TAF7	chr2:64075629-64077259	H1-hESC	embryonic stem cell:	n/a	n/a
37	TAL1	chr2:64077820-64078018	K562	blood:	n/a	n/a
38	TBP	chr2:64076401-64077290	H1-hESC	embryonic stem cell:	n/a	n/a
39	TCF12	chr2:64076572-64077038	H1-hESC	embryonic stem cell:	n/a	chr2:64076808-64076815
40	TEAD4	chr2:64076485-64077086	H1-hESC	embryonic stem cell:	n/a	n/a
41	TEAD4	chr2:64076547-64077111	H1-hESC	embryonic stem cell:	n/a	n/a
42	YY1	chr2:64076737-64077081	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:64074326..64076257-chr2:64078253..64080892,2	MCF-7	breast:
2	chr2:63917240..63919967-chr2:64076966..64079284,2	MCF-7	breast:
3	chr2:64066479..64069596-chr2:64075482..64078663,3	MCF-7	breast:
4	chr2:64078188..64080568-chr2:64088415..64090856,2	MCF-7	breast:
5	chr2:64076905..64078833-chr2:64080637..64082778,2	K562	blood:
6	chr2:64077717..64079562-chr2:64090764..64092837,2	K562	blood:
7	chr2:64065293..64070615-chr2:64075268..64080842,9	MCF-7	breast:

Variant related genes	Relation type
UGP2	TF binding region
ENSG00000169764	chromatin interactions

Extended variants
information (count: 46 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:46 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184823413	chr2:64077048-64077049	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs149667418	chr2:64077065-64077066	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs189242693	chr2:64077085-64077086	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs552279446	chr2:64077087-64077088	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs369146952	chr2:64077088-64077089	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs535909514	chr2:64077099-64077100	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs375959376	chr2:64077136-64077137	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs554350486	chr2:64077170-64077171	Flanking Active TSS Weak transcription Active TSS Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs564649424	chr2:64077270-64077271	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs572470160	chr2:64077304-64077305	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs4233930	chr2:64077305-64077306	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs558020412	chr2:64077315-64077316	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs145851183	chr2:64077320-64077321	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs140208271	chr2:64077350-64077351	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs568760237	chr2:64077391-64077392	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs145698153	chr2:64077446-64077447	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs147714207	chr2:64077448-64077449	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs540723647	chr2:64077611-64077612	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs192286772	chr2:64077690-64077691	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs532750580	chr2:64077699-64077700	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs531239191	chr2:64077723-64077724	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs114025346	chr2:64077744-64077745	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs563314622	chr2:64077765-64077766	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs185143070	chr2:64077776-64077777	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs550848651	chr2:64077796-64077797	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs550457593	chr2:64077806-64077807	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs568553081	chr2:64077814-64077815	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs77781263	chr2:64077865-64077866	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs539124819	chr2:64077878-64077879	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs547893088	chr2:64077898-64077899	Flanking Active TSS Weak transcription Enhancers Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs566214199	chr2:64078014-64078015	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs142585978	chr2:64078063-64078064	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs62136364	chr2:64078127-64078128	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs576389832	chr2:64078137-64078138	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs536907887	chr2:64078176-64078177	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs555679283	chr2:64078192-64078193	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs369141931	chr2:64078213-64078214	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs566256124	chr2:64078221-64078222	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs189890914	chr2:64078259-64078260	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs559138050	chr2:64078314-64078315	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs535077710	chr2:64078322-64078323	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs577287619	chr2:64078352-64078353	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs151277192	chr2:64078357-64078358	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs554986472	chr2:64078366-64078367	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs563096217	chr2:64078369-64078370	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs530566961	chr2:64078378-64078379	Enhancers Weak transcription Transcr. at gene 5' and 3' Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Follicular lymphoma	17699855	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	22522925	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Leukoplakia	24403051	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:234 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:64070000-64082800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr2:64070200-64084600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr2:64070200-64103000	Weak transcription	Gastric	stomach
4	chr2:64070600-64082800	Weak transcription	Fetal Stomach	stomach
5	chr2:64070600-64083800	Weak transcription	Stomach Smooth Muscle	stomach
6	chr2:64070800-64082600	Weak transcription	HUVEC	blood vessel
7	chr2:64071200-64080600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
8	chr2:64071800-64080200	Weak transcription	Monocytes-CD14+_RO01746	blood
9	chr2:64071800-64080600	Weak transcription	Pancreas	Pancrea
10	chr2:64072000-64080600	Weak transcription	Lung	lung
11	chr2:64072000-64081200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
12	chr2:64072000-64082800	Weak transcription	Fetal Muscle Trunk	muscle
13	chr2:64072000-64082800	Weak transcription	Placenta	Placenta
14	chr2:64072000-64084200	Weak transcription	Esophagus	oesophagus
15	chr2:64072200-64079600	Weak transcription	Primary monocytes fromperipheralblood	blood
16	chr2:64072600-64084600	Weak transcription	Hela-S3	cervix
17	chr2:64073000-64081800	Weak transcription	Colonic Mucosa	Colon
18	chr2:64073000-64083200	Weak transcription	Fetal Muscle Leg	muscle
19	chr2:64073200-64078400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
20	chr2:64073400-64078600	Weak transcription	Primary B cells from cord blood	blood
21	chr2:64073400-64079000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr2:64073400-64080600	Weak transcription	Spleen	Spleen
23	chr2:64074000-64077200	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
24	chr2:64074000-64079200	Weak transcription	Sigmoid Colon	Sigmoid Colon
25	chr2:64074000-64079600	Weak transcription	Rectal Mucosa Donor 29	rectum
26	chr2:64074600-64077200	Flanking Active TSS	Dnd41	blood
27	chr2:64074600-64082000	Enhancers	Fetal Heart	heart
28	chr2:64075200-64077800	Active TSS	H1 Cell Line	embryonic stem cell
29	chr2:64075200-64083000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr2:64075600-64077400	Enhancers	Cortex derived primary cultured neurospheres	brain
31	chr2:64075600-64077800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
32	chr2:64075600-64078400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
33	chr2:64075800-64077200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
34	chr2:64075800-64078000	Enhancers	Primary T killer memory cells from peripheral blood	blood
35	chr2:64075800-64078200	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
36	chr2:64075800-64078600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
37	chr2:64075800-64078800	Enhancers	Primary T helper naive cells from peripheral blood	blood
38	chr2:64075800-64080600	Weak transcription	Left Ventricle	heart
39	chr2:64075800-64081400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr2:64075800-64081800	Enhancers	Primary T helper cells PMA-I stimulated	--
41	chr2:64076000-64077400	Flanking Active TSS	Muscle Satellite Cultured Cells	--
42	chr2:64076000-64077400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr2:64076000-64077400	Flanking Active TSS	Liver	Liver
44	chr2:64076000-64077400	Enhancers	Duodenum Smooth Muscle	Duodenum
45	chr2:64076000-64077400	Enhancers	Fetal Kidney	kidney
46	chr2:64076000-64077600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr2:64076000-64077600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr2:64076000-64077600	Enhancers	NH-A	brain
49	chr2:64076000-64078000	Enhancers	Pancreatic Islets	Pancreatic Islet
50	chr2:64076000-64078000	Enhancers	HSMM	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links